z-logo
open-access-imgOpen Access
Affinity Maturation Enhances Antibody Specificity but Compromises Conformational Stability
Author(s) -
Laila Shehata,
Daniel P. Maurer,
Anna Z. Wec,
Asparouh Lilov,
Elizabeth Champney,
Tingwan Sun,
Kimberly Archambault,
Irina Burnina,
Heather Lynaugh,
Xiaoyong Zhi,
Yingda Xu,
Laura M. Walker
Publication year - 2019
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2019.08.056
Subject(s) - somatic hypermutation , monoclonal antibody , antibody , affinity maturation , cell , b cell receptor , b cell , breakpoint cluster region , receptor , microbiology and biotechnology , biology , chemistry , computational biology , biochemistry , immunology
Monoclonal antibodies (mAbs) have recently emerged as one of the most promising classes of biotherapeutics. A potential advantage of B cell-derived mAbs as therapeutic agents is that they have been subjected to natural filtering mechanisms, which may enrich for B cell receptors (BCRs) with favorable biophysical properties. Here, we evaluated 400 human mAbs for polyreactivity, hydrophobicity, and thermal stability using high-throughput screening assays. Overall, mAbs derived from memory B cells and long-lived plasma cells (LLPCs) display reduced levels of polyreactivity, hydrophobicity, and thermal stability compared with naive B cell-derived mAbs. Somatic hypermutation (SHM) is inversely associated with all three biophysical properties, as well as BCR expression levels. Finally, the developability profiles of the human B cell-derived mAbs are comparable with those observed for clinical mAbs, suggesting their high therapeutic potential. The results provide insight into the biophysical consequences of affinity maturation and have implications for therapeutic antibody engineering and development.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom